FDA Inspection 1250606 — Good Samaritan Hospital Blood Bank
The FDA completed an inspection of Good Samaritan Hospital Blood Bank on Sep 26, 2024 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 26, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Los Angeles, CA (United States)